Bengaluru | December 15, 2025
A cohort of five Swiss startups will be in India from February 16 to February 21, part of HealthTech India 2026, powered by Innosuisse and managed by Swissnex. From medtech and biotech to lifesciences, these Swiss companies reflect Switzerland’s innovation strength as they visit India to explore collaboration opportunities across the health sector.
Growing healthcare challenges in India opens up opportunities, and the technologies offered by these startups have the potential to transform the healthcare sector and address gaps in preventive care, regenerative medicine and advanced therapeutics.
During their stay in Bengaluru, the startups will engage with Indian startups, corporates and research institutions to explore opportunities to collaborate and co-innovate. On February 17 and 18, they will take the stage to pitch their solutions to investors during BioAsia 2026.
The participating startups are:
- Aseptuva | Aseptuva is working to prevent infections that patients can catch in hospitals. It has developed a way to disinfect medical catheters using UV-C light, killing germs on and around them. Since catheters are a common source of serious infections, this technology could help reduce hospital stays, ease pressure on healthcare staff and save lives.
- Baxiva | Baxiva is working on new vaccines to fight bacterial infections. Its main focus is on infections caused by E. coli, a major source of antibiotic-resistant disease worldwide, including urinary tract and serious invasive infections. Using its own vaccine technology, Baxiva aims to protect against multiple strains at once and help reduce the spread of antibiotic-resistant infections.
- Bewe | Bewe uses a neuroscience-backed mobile game to reduce cravings and consumption of unhealthy foods and improve long-term health. The gamified experience helps rewire automatic responses, leading to sustained behavioural change without strict diets or willpower struggles.
- Cellx Biosolutions | Cellx Biosolutions helps chemical and pharma industries treat chemical waste sustainably. It uses patented microfluidic and robotic technologies to identify and deploy bacteria that break down pollutants such as microplastics, PFAS (per- and polyfluoroalkyl substances which are a large group of man-made chemicals used in products like non-stick cookware, waterproof clothing, food packaging and are often called “forever chemicals” because they don’t break down easily in the environment or the human body), pesticides and pharmaceutical residues in a cost-efficient and environmentally friendly way.
- Precise Health | Precise Health is tackling antimicrobial resistance (AMR) with an AI-driven phage therapy platform. Its products, PhageMatch™ and PhageTailor™, allow clinicians to rapidly identify or engineer the right phage treatment, while building a unique database licensable to pharma.